Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001641172-25-011130

Options or other derivatives

  • CEO acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-15 Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note +0 D
Loading xslF345X05/ownership.xml…